M.D. PhD. Professor of Cellular Immunotherapy and Senior Consultant in Clinical Immunology. Former head of the Swedish Clinical Immunology Society, and now vice chairman SLS (Swedish Society of Medicine) Research Committee The Swedish Research Council and the Swedish Cancer Society have continuously supported Ola’s research since 1999, and he has received various competitive grants from the European Union and Swedish Governmental Agency for Innovation Systems for the development of immunological therapeutics. Ola has an M.D and Ph.D. from Uppsala University in Sweden, and did his postdoctoral research at the Scripps Research Institute in the United States. In 2013 rewarded with the Athena Prize.
Master of Business Administration from Gothenburg University and Phd. study Gothenburg University. Guest professor of Tsinghua University, Beijing 2003 and honorary Dean of Wuhan International Trade University 2006. President and Dean of IHM Business School 1993-2003. Founder of BRL in 2003 and Co-founder of Foundation Asia Pacific Ltd (FAP). Senior consultant at Deloitte and Bain. Chairman in the business magazine Chef for several years and member of the board at Vigmed AB, NeuroVive Asia Inc and Vigmed China Ltd. Participated in several start-up’s, M&A and business deals in Asia.
Gunnar has a B.A. in Finance from Lunds University and appointed Captain in the reserve in the Royal Swedish Marines. He has over twentyfive years international experience from senior positions in listed and unlisted companies active in areas such as the chemicals/manufacturing industry, shipping/offshore industry, electronic/mobile phones, gaming and international banks. Gunnar held senior positions in the Perstorp Group during 1994-2010. Since 2010 Gunnar has been an independent consultat upholding positions such as CFO for Rederi AB Transatlantic (publ) and Doro AB (publ) both listed on Nasdaq Stockholm. Gunnars latest position was Head of Investor Relations & Communication in the gaming company Cherry AB (publ) listed on AktieTorget, Stockholm.